The functions of the Statistical Center are: (1) to provide for the review of all proposed protocols and to comment on the feasibility, experimental design, and appropriate number of patients for each study; (2) to provide for the central registration of all patients and studies; (3) to provide for the surveillance, monitoring, storage, and processing of data collected during SWOG studies in the Adult Division; (4) to analyze and write up the results of clinical studies in cooperation with the Chairman of each study; (5) to work in close cooperation with the Chairman of the SWOG in the administration of group studies; (6) to conduct workshops and seminars on functions related to Statistical Center activities, such as data management, computer programming, and statistical aspects of clinical studies; (7) to perform research on the statistical aspects of studies to improve the efficacy of ongoing and future clinical trials; and (8) to carry out long term analyses of survival and late effects to determine, for example, whether survival has been improving with calendar time, and which clinical and laboratory variables seem important in relation to the response and survival of cancer patents. The Statistical Center carries out essentially the functions above for the Southwest Oncology Group (Adult Division) and the Pediatric Intergroup Rhabdomyosarcoma, Ewing's Sarcoma and Lymphoma studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA030138-05
Application #
3557127
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1981-04-01
Project End
1987-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
La, Trang H; Wolden, Suzanne L; Su, Zheng et al. (2011) Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:206-12
La, Trang H; Wolden, Suzanne L; Rodeberg, David A et al. (2011) Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:1151-7
Minn, A Yuriko; Lyden, Elizabeth R; Anderson, James R et al. (2010) Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group. J Clin Oncol 28:4228-32
Wharam, Moody D; Meza, Jane; Anderson, James et al. (2004) Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 22:1902-8
Breneman, John C; Lyden, Elizabeth; Pappo, Alberto S et al. (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21:78-84
Baker, K Scott; Anderson, James R; Lobe, Thom E et al. (2002) Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 20:4428-33
Crist, W M; Anderson, J R; Meza, J L et al. (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091-102
Baker, K S; Anderson, J R; Link, M P et al. (2000) Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18:2427-34
Raney, R B; Asmar, L; Vassilopoulou-Sellin, R et al. (1999) Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pedia Med Pediatr Oncol 33:362-71
Smith, M A; Rubinstein, L; Anderson, J R et al. (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:569-77

Showing the most recent 10 out of 66 publications